Questions across 2 calls

Vishal Daga

Firm not listed in source transcripts

Laurus Labs Limited

Analysts/Institutional Investor Meet/Con. Call Updates Laurus Labs Limited has informed the Exchange about Transcript · 2025-10-23

Congratulations on a great set of numbers. I have a couple of questions. One, we recently got to know that there was a breakthrough in the HIV drug with a $40 jab that can come for the developing nations. Does that impact Laurus in any way? It is going to get, I think, rolled out in '27. If it does, is there any way we are going to mitigate the impact?

Just one more question. On the Bio, Laurus Bio, we saw a good uptick this quarter. What would be a steady-state run rate that you are targeting from a capacity expansion perspective for, say, '27 or '28?

Laurus Labs Limited CC-Oct25.pdf · 2025-10-23

Congratulations on a great set of numbers. I have a couple of questions. One, we recently got to know that there was a breakthrough in the HIV drug with a $40 jab that can come for the developing nations. Does that impact Laurus in any way? It is going to get, I think, rolled out in '27. If it does, is there any way we are going to mitigate the impact?

Just one more question. On the Bio, Laurus Bio, we saw a good uptick this quarter. What would be a steady-state run rate that you are targeting from a capacity expansion perspective for, say, '27 or '28?